Showing 1 - 4 results of 4 for search 'Nora Isberner', query time: 0.02s
Refine Results
-
1
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Pati... by Bettina Gerner, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, Götz Ulrich Grigoleit, Sebastian Zimmermann, Max Kurlbaum, Hartwig Klinker, Nora Isberner, Oliver Scherf-Clavel
Published 2022-11-01
Article -
2
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma by Nora Isberner, Anja Gesierich, David Balakirouchenane, Bastian Schilling, Fatemeh Aghai-Trommeschlaeger, Sebastian Zimmermann, Max Kurlbaum, Alicja Puszkiel, Benoit Blanchet, Hartwig Klinker, Oliver Scherf-Clavel
Published 2022-09-01
Article -
3
Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter Study by David Meintrup, Stefan Borgmann, Karlheinz Seidl, Melanie Stecher, Carolin E. M. Jakob, Lisa Pilgram, Christoph D. Spinner, Siegbert Rieg, Nora Isberner, Martin Hower, Maria Vehreschild, Siri Göpel, Frank Hanses, Martina Nowak-Machen
Published 2021-08-01
Article -
4
Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort by Noemi F. Freise, Smaranda Gliga, Johannes Fischer, Nadine Lübke, Matthias Lutterbeck, Miriam Schöler, Edwin Bölke, Hans Martin Orth, Torsten Feldt, Christoph Roemmele, Dominik Wilke, Jochen Schneider, Kai Wille, Christian Hohmann, Richard Strauss, Martin Hower, Andreas Ruf, Joerg Schubert, Nora Isberner, Melanie Stecher, Lisa Pilgram, Jörg J. Vehreschild, LEOSS Study Group, Frank Hanses, Tom Luedde, Björn Jensen
Published 2022-11-01
Article